Skip to content
lifestyle.successfuldaily.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Muna Therapeutics
Muna Therapeutics Announces Positive Phase 1 Results Supporting Potential of Oral Small-Molecule TREM2 Modulator, MNA-001, in Alzheimer’s Disease
October 21, 2026
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
June 30, 2026
Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer’s
June 4, 2026